[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 23, Issue 2 (Bimonthly 2019) ::
Feyz Med Sci J 2019, 23(2): 153-157 Back to browse issues page
Evaluation of Bcl2/BAX genes expression ratio as a marker of inflammatory bowel disease
Fariba Javadinia , Zeinab Khazaei Koohpar * , Hamid Asadzadeh Aghdaei
Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, I. R. Iran. , dz.khazaei@gmail.com
Abstract:   (2911 Views)
Background: Apoptosis is an essential physiological process to maintain immune homeostasis. T-cell incorrect apoptosis appears to be involved in chronic inflammatory diseases such as inflammatory bowel disease (IBD). The aim of this study was to evaluate the Bcl2/BAX genes expression ratio in patients with IBD (Crohn’s disease and ulcerative colitis) compared to healthy persons.
Materials and Methods: This case-control study was conducted on 49 patients with IBD and 20 healthy subjects. Blood samples were collected from the patients and healthy subjects after receiving complete information and obtaining consent. Then, white blood cells were isolated by the Salting Out technique. After RNA extraction and cDNA synthesis, the Bcl2/BAX expression level was quantitatively measured by the real-time PCR method in the patients and healthy subjects.
Results: The results showed that the Bcl2/BAX genes expression ratio in peripheral blood T-cells was not significantly different in patients with IBD compared to the healthy subjects (P=0.06).
Conclusion: It seems that change is not evident in Bcl2/BAX genes expression ratio in peripheral blood T-cells in the patients with IBD.
Keywords: Apoptosis, BAX, Bcl2, Inflammatory bowel disease
Full-Text [PDF 255 kb]   (1443 Downloads)    
Type of Study: Research | Subject: General
Received: 2018/07/16 | Revised: 2019/06/17 | Accepted: 2019/02/26 | Published: 2019/06/10
References
1. Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res 2014; 7: 113-20.
2. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474(7351): 307-17.
3. Mudter J, Neurath MF. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 2007; 56(2): 293-303.
4. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411(6837): 599-603.
5. Itoh J, de La Motte C, Strong SA, Levine AD, Fiocchi C. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 2001; 49(1): 35-41.
6. Ina K, Itoh J, Fukushima K, Kusugami K, Yamaguchi T, Kyokane K, et al. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 1999; 163(2): 1081-90.
7. Elmore S. Apoptosis: a review of programmed cell death. Toxicologic Pathol 2007; 35(4): 495-516.
8. Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 2011; 30: 87.
9. Zhang S, Tang MB, Luo HY, Shi CH, Xu YM. Necroptosis in neurodegenerative diseases: a potential therapeutic target. Cell Death Dis 2017; 8(6): e2905.
10. Bride K, Teachey D. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. F1000 Res 2017; 6: 1928.
11. Li M, Zhang S, Qiu Y, He Y, Chen B, Mao R, et al. Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3. Cell Death Dis 2017; 8(3): e2699.
12. Ten Hove T, Van Montfrans C, Peppelenbosch MP, Van Deventer SJ. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 2002; 50(2): 206-11.
13. Wilson JC, Furlano RI, Jick SS, Meier CR. Inflammatory Bowel Disease and the Risk of Autoimmune Diseases. J Crohn's Colitis 2016; 10(2): 186-93.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Javadinia F, Khazaei Koohpar Z, Asadzadeh Aghdaei H. Evaluation of Bcl2/BAX genes expression ratio as a marker of inflammatory bowel disease . Feyz Med Sci J 2019; 23 (2) :153-157
URL: http://feyz.kaums.ac.ir/article-1-3638-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 23, Issue 2 (Bimonthly 2019) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.04 seconds with 46 queries by YEKTAWEB 4660